Company Overview
Sales
742
Cr
Growth: 6.4%
Profit after Tax
109
Cr
Growth:
16.1%
Small Cap
3,031
Cr
P/E:
27.7x
Industry P/E: 36.7x
Fundamentals
| Sales (Cr) |
₹ 742 |
| Growth |
6.4% |
| EBITDA |
19.3% |
| P/S |
4.1x |
| Dividend |
0.0% |
| P/E |
27.7x |
| Book Value |
₹ 146 |
| PEG Ratio |
N/A |
| ROE |
28.7% |
| P/B |
N/A |
Shareholding Pattern
Increase
Decrease
No change
Wyeth Limited (Wyeth) the Indian subsidiary of US-based Pharma Company Wyeth and now a Pfizer group company, is a global leader in pharmaceutical, consumer healthcare and animal health products. It was established in 1947 as a private limited company under the name Lederle Laboratories (India) Ltd. In 1962, the name was changed to Cyanamid India Ltd. The company became a public enterprise in 1965.
